1. Home
  2. PFX vs FBIO Comparison

PFX vs FBIO Comparison

Compare PFX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFX
  • FBIO
  • Stock Information
  • Founded
  • PFX 2010
  • FBIO 2006
  • Country
  • PFX United States
  • FBIO United States
  • Employees
  • PFX N/A
  • FBIO N/A
  • Industry
  • PFX Finance: Consumer Services
  • FBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFX Finance
  • FBIO Health Care
  • Exchange
  • PFX Nasdaq
  • FBIO Nasdaq
  • Market Cap
  • PFX 96.4M
  • FBIO 88.7M
  • IPO Year
  • PFX N/A
  • FBIO N/A
  • Fundamental
  • Price
  • PFX $42.44
  • FBIO $2.75
  • Analyst Decision
  • PFX
  • FBIO Strong Buy
  • Analyst Count
  • PFX 0
  • FBIO 2
  • Target Price
  • PFX N/A
  • FBIO $16.50
  • AVG Volume (30 Days)
  • PFX 1.8K
  • FBIO 341.4K
  • Earning Date
  • PFX 12-16-2025
  • FBIO 11-14-2025
  • Dividend Yield
  • PFX 3.37%
  • FBIO N/A
  • EPS Growth
  • PFX N/A
  • FBIO N/A
  • EPS
  • PFX 3.06
  • FBIO N/A
  • Revenue
  • PFX $23,958,590.00
  • FBIO $62,303,000.00
  • Revenue This Year
  • PFX $10.24
  • FBIO $31.85
  • Revenue Next Year
  • PFX N/A
  • FBIO $44.43
  • P/E Ratio
  • PFX $13.88
  • FBIO N/A
  • Revenue Growth
  • PFX 7.47
  • FBIO N/A
  • 52 Week Low
  • PFX $41.00
  • FBIO $1.33
  • 52 Week High
  • PFX $57.40
  • FBIO $4.20
  • Technical
  • Relative Strength Index (RSI)
  • PFX 39.13
  • FBIO 55.02
  • Support Level
  • PFX $41.00
  • FBIO $2.40
  • Resistance Level
  • PFX $43.00
  • FBIO $2.76
  • Average True Range (ATR)
  • PFX 0.67
  • FBIO 0.16
  • MACD
  • PFX 0.15
  • FBIO 0.03
  • Stochastic Oscillator
  • PFX 55.82
  • FBIO 94.59

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: